Ovarian cancer is a heterogeneous disease

Cancer Genetics and Cytogenetics

Volumn 161, Issue 2, 2005, Pages 170-173

  Wang, Vivian ^a   Li, Cheng ^b   Lin, Ming ^b   Welch, William ^a   Bell, Deborah ^c   Wong, Yuk Fu ^d   Berkowitz, Ross ^a   Mok, Samuel C ^a   Bandera, Christina A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER GRADING; CELL TYPE; CHROMOSOME STRUCTURE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPUTER PROGRAM; DISEASE MARKER; DNA POLYMORPHISM; EARLY DIAGNOSIS; ENDOMETRIOID CARCINOMA; EVALUATION; FEMALE; FISHER EXACT TEST; GENE EXPRESSION PROFILING; GENE LOSS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY METASTASIS; PHENOTYPE; PRIORITY JOURNAL;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; OVARIAN NEOPLASMS;

EID: 23644444497     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.12.014     Document Type: Article

References (16)

1. Cancer facts and figures 2005 2005 American Cancer Society Atlanta, GA
2. C.C. Boring, T.S. Squires, T. Tong, and S. Montgomery Cancer statistics, 1994 CA Cancer J Clin 44 1994 7 26
3. M. Schuijer, and E.M. Berns TP53 and ovarian cancer Hum Mutat 21 2003 285 291
4. L.M. Kmet, L.S. Cook, and A.M. Magliocco A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors Cancer 97 2003 389 404
5. C.M. Chen, and R.R. Behringer Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis Genes Dev 18 2004 320 332
6. L.J. Havrilesky, A.A. Alvarez, R.S. Whitaker, J.R. Marks, and A. Berchuck Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations Gynecol Oncol 83 2001 491 500
7. S.C. Mok, W.Y. Chan, K.K. Wong, K.K. Cheung, C.C. Lau, S.W. Ng, A. Baldini, C.V. Colitti, C.O. Rock, and R.S. Berkowitz DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer Oncogene 16 1998 2381 2387
8. A. Bali, P.M. O'Brien, L.S. Edwards, R.L. Sutherland, N.F. Hacker, and S.M. Henshall Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer Clin Cancer Res 10 2004 5168 5177
9. D. Katsaros, W. Cho, R. Singal, S. Fracchioli, I.A. Rigault De La Longrais, R. Arisio, M. Massobrio, M. Smith, W. Zheng, J. Glass, and H. Yu Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer Gynecol Oncol 94 2004 685 692
10. S.F. Serov, and R.E. Scully Histological typing of ovarian tumors. International Histological Classification of Tumors 9 1993 World Health Organization Geneva
11. I.G. Campbell, S. Morland, and A. Hitchcock Endometriosis and the relationship with ovarian cancer F. Sharp T. Blackett J. Derek R. Bast Ovarian cancer 5 1998 ISIS Medical Media Oxford 159 170
12. A. Blaustein R.J. Kurman Blaustein's pathology of the female genital tract 5th ed. 2002 Springer New York
13. T. Kuukasjarvi, M. Tanner, S. Pennanen, R. Karhu, T. Visakorpi, and J. Isola Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization Genes Chromosomes Cancer 18 1997 94 101
14. M. Lin, L.J. Wei, W.R. Sellers, M. Lieberfarb, W.H. Wong, and C. Li dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data Bioinformatics 20 8 2004 May 22 1233 1240
15. I.P. Tomlinson, M.B. Lambros, and R.R. Roylance Loss of heterozygosity analysis: practically and conceptually flawed? Genes Chromosomes Cancer 34 2002 349 353
16. M.O. Hoque, C.C. Lee, P. Cairns, M. Schoenberg, and D. Sidransky Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis Cancer Res 63 2003 2216 2222